Mack-Cali Signs Lease With RadPharm, Inc. in Princeton

05/22/2006 Category: Leasing and Development

Growing Pharmaceutical Company Leases Approximately 43,500 Square Feet at Princeton Overlook

Cranford, New Jersey—May 22, 2006—Mack-Cali Realty Corporation (NYSE: CLI) today announced that RadPharm, Inc., a provider of medical imaging and review services, has signed a new lease for 43,486 square feet at Princeton Overlook in Princeton, New Jersey. The lease carries a term of five years.

The growing pharmaceutical company is expanding and relocating its corporate headquarters from approximately 18,600 square feet at 103 Carnegie Center in Princeton, another Mack-Cali property.

Mitchell E. Hersh, president and chief executive officer of Mack-Cali, stated, "We are pleased that RadPharm, Inc. chose to relocate within our portfolio and that we were able to meet its expansion requirements." He continued, "This transaction demonstrates Mack-Cali's ability to maintain and preserve long-standing relationships with our tenants and to accommodate their ever-evolving office space needs."

Dan Ackerman, in-house director of leasing, represented Mack-Cali in the transaction. Princeton Overlook, located at 100 Overlook Center, at Route One and Alexander Road, is a four-story, 149,600 square-foot class A office building that is 100 percent leased.

Mack-Cali Realty Corporation is a fully-integrated, self-administered, self-managed real estate investment trust (REIT) providing management, leasing, development, construction and other tenant-related services for its class A real estate portfolio. Mack-Cali currently owns or has interests in 297 properties, primarily office and office/flex buildings located in the Northeast, totaling approximately 33.6 million square feet. The properties enable the Company to provide a full complement of real estate opportunities to its diverse base of approximately 2,400 tenants. Additional information on Mack-Cali Realty Corporation is available on the Company's website at www.mack-cali.com.

Statements made in this press release may be forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements can be identified by the use of words such as "may," "will," "should," "expect," "plan," "anticipate," "estimate," "continue," or comparable terminology. Such forward-looking statements are inherently subject to certain risks, trends and uncertainties, many of which the Company cannot predict with accuracy and some of which the Company might not even anticipate, and involve factors that may cause actual results to differ materially from those projected or suggested. Readers are cautioned not to place undue reliance on these forward-looking statements and are advised to consider the factors listed above together with the additional factors under the headings "Disclosure Regarding Forward-Looking Statements" and "Risk Factors" in the Company's Annual Reports on Form 10-K. The Company assumes no obligation to update or supplement forward-looking statements that become untrue because of subsequent events, new information or otherwise.